RESUMO
The mortality of ovarian cancer (OC) has long been the highest among gynecological malignancies. Although OC is considered to be an immunogenic tumor, the effect of immunotherapy is not satisfactory. The immunosuppressive microenvironment is one reason for this, and the absence of recognized effective antigens for vaccines is another. Chemotherapy, as one of the most commonly used treatment for OC, can produce chemotherapy-associated antigens (CAAs) during treatment and show the effect of in situ vaccine. Herein, we designed an antigen capture nano-vaccine NP-TP1@M-M with tumor targeting peptide TMTP1 and dendritic cell (DC) receptor mannose assembled on the surface and adjuvant monophosphoryl lipid A (MPLA) encapsulated in the core of poly (D, L-lactide-co-glycolide) (PLGA) nanoparticles. PLGA itself possessed the ability of antigen capture. TMTP1 was a tumor-homing peptide screened by our research team, which held extensive and excellent tumor targeting ability. After these modifications, NP-TP1@M-M could capture and enrich more tumor-specific antigens after chemotherapy, stimulate DC maturation, activate the adaptive immunity and combined with immune checkpoint blockade to maximize the release of the body's immune potential, providing an eutherapeutic strategy for the treatment of OC.
Assuntos
Antígenos de Neoplasias , Antígeno B7-H1 , Vacinas Anticâncer , Nanopartículas , Neoplasias Ovarianas , Feminino , Neoplasias Ovarianas/tratamento farmacológico , Animais , Camundongos , Vacinas Anticâncer/uso terapêutico , Nanopartículas/química , Linhagem Celular Tumoral , Antígenos de Neoplasias/imunologia , Humanos , Células Dendríticas/efeitos dos fármacos , Peptídeos/química , Peptídeos/farmacologia , Lipídeo A/análogos & derivados , Lipídeo A/química , Lipídeo A/farmacologia , Imunoterapia/métodos , Copolímero de Ácido Poliláctico e Ácido Poliglicólico/química , Antineoplásicos/farmacologia , Antineoplásicos/química , Camundongos Endogâmicos BALB C , Inibidores de Checkpoint Imunológico/farmacologia , NanovacinasRESUMO
The ATP-binding cassette (ABC) transporter, MsbA, plays a pivotal role in lipopolysaccharide (LPS) biogenesis by facilitating the transport of the LPS precursor lipooligosaccharide (LOS) from the cytoplasmic to the periplasmic leaflet of the inner membrane. Despite multiple studies shedding light on MsbA, the role of lipids in modulating MsbA-nucleotide interactions remains poorly understood. Here we use native mass spectrometry (MS) to investigate and resolve nucleotide and lipid binding to MsbA, demonstrating that the transporter has a higher affinity for adenosine 5'-diphosphate (ADP). Moreover, native MS shows the LPS-precursor 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo)2-lipid A (KDL) can tune the selectivity of MsbA for adenosine 5'-triphosphate (ATP) over ADP. Guided by these studies, four open, inward-facing structures of MsbA are determined that vary in their openness. We also report a 2.7 Å-resolution structure of MsbA in an open, outward-facing conformation that is not only bound to KDL at the exterior site, but with the nucleotide binding domains (NBDs) adopting a distinct nucleotide-free structure. The results obtained from this study offer valuable insight and snapshots of MsbA during the transport cycle.
Assuntos
Transportadores de Cassetes de Ligação de ATP , Difosfato de Adenosina , Trifosfato de Adenosina , Espectrometria de Massas , Transportadores de Cassetes de Ligação de ATP/metabolismo , Transportadores de Cassetes de Ligação de ATP/química , Trifosfato de Adenosina/metabolismo , Difosfato de Adenosina/metabolismo , Espectrometria de Massas/métodos , Proteínas de Bactérias/metabolismo , Proteínas de Bactérias/química , Lipopolissacarídeos/metabolismo , Lipídeo A/metabolismo , Lipídeo A/química , Ligação Proteica , Modelos Moleculares , Cristalografia por Raios X , Lipídeos/química , Escherichia coli/metabolismo , Conformação ProteicaRESUMO
Anticancer chemo-immunotherapy has gained considerable attention across various scientific domains as a prospective approach for the comprehensive eradication of malignant tumors. Recent research has particularly been focused on traditional anthracycline chemo drugs, such as doxorubicin and mitoxantrone. These compounds trigger apoptosis in tumor cells and evoke immunogenic cell death (ICD). ICD is a pivotal initiator of the cancer-immunity cycle by facilitating the release of damage-associated molecular patterns (DAMPs). The resultant DAMPs released from cancer cells effectively activate the immune system, resulting in an increase in tumor-infiltrating T cells. In this study, we have innovated a co-delivery strategy involving folate-modified liposomes to deliver doxorubicin and monophosphoryl lipid A (MPLA) simultaneously to tumor tissue. The engineered liposomes exploit the overexpression of folate receptors within the tumor tissues. Delivered doxorubicin initiates ICD at the tumor cells, further enhancing the immunogenic stimulus. Additionally, MPLA helps T cell priming by activating antigen-presenting cells. This intricate interplay culminates in a synergistic effect, ultimately resulting in an augmented and potentiated anticancer chemo-immunotherapeutic liposomal treatment.
Assuntos
Doxorrubicina , Morte Celular Imunogênica , Imunoterapia , Lipídeo A , Lipossomos , Receptor 4 Toll-Like , Lipossomos/química , Doxorrubicina/farmacologia , Doxorrubicina/química , Animais , Morte Celular Imunogênica/efeitos dos fármacos , Humanos , Receptor 4 Toll-Like/agonistas , Receptor 4 Toll-Like/metabolismo , Camundongos , Lipídeo A/análogos & derivados , Lipídeo A/química , Lipídeo A/farmacologia , Neoplasias/tratamento farmacológico , Neoplasias/imunologia , Neoplasias/terapia , Linhagem Celular Tumoral , Feminino , Antineoplásicos/química , Antineoplásicos/farmacologia , Ácido Fólico/químicaRESUMO
This study describes the design and synthesis of five TF-based cancer vaccine candidates using a lipid A mimetic as the carrier and a built-in adjuvant. All synthesized conjugates elicited robust and consistent TF-specific immune responses in mice without external adjuvants. Immunological studies subsequently conducted in wild-type and TLR4 knockout C57BL/6 mice demonstrated that the activation of TLR4 was the main reason that the synthesized lipid A mimetics increased the TF-specific immune responses. All antisera induced by these conjugates can specifically recognize, bind to, and induce the lysis of TF-positive cancer cells. Moreover, representative conjugates 2 and 3 could effectively reduce the growth of tumors and prolong the survival time of mice in vivo, and the efficacies were better than glycoprotein TF-CRM197 with alum adjuvant. Lipid A mimetics could therefore be a promising platform for the development of new carbohydrate-based vaccine carriers with self-adjuvanting properties for the treatment of cancer.
Assuntos
Adjuvantes Imunológicos , Vacinas Anticâncer , Desenho de Fármacos , Lipídeo A , Camundongos Endogâmicos C57BL , Animais , Lipídeo A/análogos & derivados , Lipídeo A/química , Lipídeo A/farmacologia , Vacinas Anticâncer/imunologia , Vacinas Anticâncer/farmacologia , Vacinas Anticâncer/síntese química , Adjuvantes Imunológicos/farmacologia , Adjuvantes Imunológicos/síntese química , Adjuvantes Imunológicos/química , Camundongos , Camundongos Knockout , Humanos , Feminino , Receptor 4 Toll-Like/metabolismo , Linhagem Celular TumoralRESUMO
Bacterial endotoxins (lipopolysaccharides (LPSs)) are important mediators of inflammatory processes induced by Gram-negative microorganisms. LPSs are the key inducers of septic shock due to a Gram-negative bacterial infection; thus, the structure and functions of LPSs are of specific interest. Often, highly purified bacterial endotoxins must be isolated from small amounts of biological material. Each of the currently available methods for LPS extraction has certain limitations. Herein, we describe a rapid and simple microscale method for extracting LPSs. The method consists of the following steps: ultrasonic destruction of the bacterial material, LPS extraction via heating, LPS purification with organic solvents, and treatment with proteinase K. LPSs that were extracted by using this method contained less than 2-3% protein and 1% total nucleic acid. We also demonstrated the structural integrity of the O-antigen and lipid A via the sodium dodecyl-sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS) methods, respectively. We demonstrated the ability of the extracted LPSs to induce typical secretion of cytokines and chemokines by primary macrophages. Overall, this method may be used to isolate purified LPSs with preserved structures of both the O-antigen and lipid A and unchanged functional activity from small amounts of bacterial biomass.